<description>&lt;p&gt;In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.&lt;/p&gt;</description>

Neurology Today in 5

American Academy of Neurology

Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

NOV 20, 20254 MIN
Neurology Today in 5

Artificial sweeteners cognition concerns, drug company payments and prescribing decisions, graphene technology

NOV 20, 20254 MIN

Description

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.